SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xin Hui Magdeline Lee, Lin Xin Ong, Jing Yi Vanessa Cheong, Rehena Sultana, Rajeshwar Rao, Hwee Hoon Lim, Xiao Mei Ding, Wen Yin Loh, Monika Punan, Wen Chin Chiang, A stepwise approach in the management of chronic spontaneous urticaria in children, Asia Pacific Allergy, 2016, 6, 1, 16

    CrossRef

  2. 2
    Young-Min Ye, Jung-Won Park, Sang-Ha Kim, Ga-Young Ban, Ji-Hye Kim, Yoo-Seob Shin, Hyun-Young Lee, Hae-Sim Park, Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study, Allergy, Asthma & Immunology Research, 2016, 8, 2, 115

    CrossRef

  3. 3
    A.Z. Akelma, M.N. Cizmeci, E. Mete, N. Tufan, B. Bozkurt, A neglected cause for chronic spontaneous urticaria in children: Helicobacter pylori, Allergologia et Immunopathologia, 2015, 43, 3, 259

    CrossRef

  4. 4
    Jung-Ah Kim, Sujeoung Kim, Ji-Eun Kim, Ja-Yoon Gu, Hyun Ju Yoo, Hye-Ryun Kang, Hyun Kyung Kim, Activation of the Intrinsic Coagulation Pathway in Patients With Chronic Urticaria, Allergy, Asthma & Immunology Research, 2015, 7, 5, 476

    CrossRef

  5. 5
    Jingdong Yan, Yuepeng An, Ling-shu Wang, Yi Li, Suqing Yang, Acupoint stimulation for chronic urticaria: a systematic review of randomized controlled trials, European Journal of Integrative Medicine, 2015, 7, 6, 586

    CrossRef

  6. 6
    Qin Yao, Yongming Ye, Xiaoxu Liu, Zongshi Qin, Zhishun Liu, Acupuncture for patients with chronic urticaria: a systematic review protocol, BMJ Open, 2015, 5, 9, e007704

    CrossRef

  7. 7
    N. P. Conlon, A. Abramovitch, G. Murray, A. O’Hanrahan, D. Wallace, K. Holohan, N. Cleary, C. Feighery, C. Lee-Brennan, Allergy in Irish adults: a survey of referrals and outcomes at a major centre, Irish Journal of Medical Science (1971 -), 2015, 184, 2, 349

    CrossRef

  8. 8
    Roisin Fitzsimons, Lauri-Ann van der Poel, William Thornhill, George du Toit, Neil Shah, Helen A Brough, Antihistamine use in children, Archives of disease in childhood - Education & practice edition, 2015, 100, 3, 122

    CrossRef

  9. 9
    Yuval Tal, Ori Toker, Nancy Agmon-Levin, Meir Shalit, Azathioprine as a therapeutic alternative for refractory chronic urticaria, International Journal of Dermatology, 2015, 54, 3
  10. 10
    Kotaro Hiraoka, Manabu Tashiro, Thomas Grobosch, Marcus Maurer, Keiichi Oda, Jun Toyohara, Kenji Ishii, Kiichi Ishiwata, Kazuhiko Yanai, Brain histamine H1receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine, Expert Opinion on Drug Safety, 2015, 14, 2, 199

    CrossRef

  11. 11
    M. Sánchez-Borges, A. Capriles-Hulett, F. Caballero-Fonseca, Demographic and clinical profiles in patients with acute urticaria, Allergologia et Immunopathologia, 2015, 43, 4, 409

    CrossRef

  12. 12
    Sarbjit S. Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon Spector, Karin Rosén, Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study, Journal of Investigative Dermatology, 2015, 135, 1, 67

    CrossRef

  13. 13
    Young-Min Ye, Gwang Cheon Jang, Sun Hee Choi, Jeongmin Lee, Hye-Soo Yoo, Kyung Hee Park, Meeyong Shin, Jihyun Kim, Suh-Young Lee, Jeong-Hee Choi, Youngmin Ahn, Hae-Sim Park, Yoon-Seok Chang, Jae-Won Jeong, Sooyoung Lee, KAAACI Work Group report on the management of chronic urticaria, Allergy, Asthma & Respiratory Disease, 2015, 3, 1, 3

    CrossRef

  14. 14
    P.M. Silva, A.C. Costa, A. Mendes, M.P. Barbosa, Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria, Allergologia et Immunopathologia, 2015, 43, 2, 168

    CrossRef

  15. You have free access to this content15
    M. Maurer, M.K. Church, M. Gonçalo, G. Sussman, M. Sánchez-Borges, Management and treatment of chronic urticaria (CU), Journal of the European Academy of Dermatology and Venereology, 2015, 29,
  16. 16
    Maria Teresa Ventura, Nicoletta Cassano, Paolo Romita, Michelangelo Vestita, Caterina Foti, Gino Antonio Vena, Management of Chronic Spontaneous Urticaria in the Elderly, Drugs & Aging, 2015, 32, 4, 271

    CrossRef

  17. 17
    Javad Ghaffari, Soheila Shahmohammadi, Hossein Ashrafi, Ali Reza Ranjbar, Negar Ghaffari, Omalizumab (Xolair) in Children above 12 Years With Chronic Urticaria: A Review of Literature, Journal of Pediatrics Review, 2015, 3, 1

    CrossRef

  18. 18
    Maciej Pawłowski, Iwona Stelmach, Pokrzywka spontaniczna o nieznanej przyczynie – opis przypadku, Alergologia Polska - Polish Journal of Allergology, 2015, 2, 2, 89

    CrossRef

  19. 19
    Michael S. Broder, Karina Raimundo, Evgeniya Antonova, Eunice Chang, Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria, American Journal of Clinical Dermatology, 2015, 16, 4, 313

    CrossRef

  20. 20
    Elizabeth Guevara-Gutierrez, Sonia Bonilla-Lopez, Socorro Hernández-Arana, Alberto Tlacuilo-Parra, Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study, Journal of Dermatological Treatment, 2015, 26, 6, 548

    CrossRef

  21. 21
    Ljerka Prester, Seafood Allergy, Toxicity, and Intolerance: A Review, Journal of the American College of Nutrition, 2015, 1

    CrossRef

  22. 22
    Zbigniew Bartuzi, Zenon Brzoza, Magdalena Czarnecka-Operacz, Jerzy Kruszewski, Jan Maj, Zbigniew Samochocki, Bolesław Samoliński, Jacek Szepietowski, Stanowisko zespołu ekspertów Polskiego Towarzystwa Alergologicznego i Polskiego Towarzystwa Dermatologicznego w sprawie wytycznych postępowania w pokrzywce, Alergologia Polska - Polish Journal of Allergology, 2015, 2, 1, 37

    CrossRef

  23. 23
    N. Schoepke, A. Młynek, K. Weller, M.K. Church, M. Maurer, Symptomatic dermographism: an inadequately described disease, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 4
  24. 24
    Sarah Mitchell, Maria-Magdalena Balp, Miny Samuel, Doreen McBride, Marcus Maurer, Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments, International Journal of Dermatology, 2015, 54, 9
  25. 25
    Giuliana Ferrante, Valeria Scavone, Maria Muscia, Emilia Adrignola, Giovanni Corsello, Giovanni Passalacqua, Stefania La Grutta, The care pathway for children with urticaria, angioedema, mastocytosis, World Allergy Organization Journal, 2015, 8, 1, 5

    CrossRef

  26. 26
    Tse Wen Chang, Christina Chen, Chien-Jen Lin, Martin Metz, Martin K. Church, Marcus Maurer, The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria, Journal of Allergy and Clinical Immunology, 2015, 135, 2, 337

    CrossRef

  27. 27
    Susana Córdoba, Cristina Martínez-Morán, Jesús Borbujo, Urticaria aguda y crónica, FMC - Formación Médica Continuada en Atención Primaria, 2015, 22, 7, 387

    CrossRef

  28. 28
    Jaclyn Quirt, Hermenio Lima, Susan Waserman, Urticaria: a Multidisciplinary Disease. Where Are We Now?, Current Dermatology Reports, 2015, 4, 1, 8

    CrossRef

  29. 29
    T. Zuberbier, W. Aberer, R. Asero, C. Bindslev-Jensen, Z. Brzoza, G.W. Canonica, M.K. Church, L.F. Ensina, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, J. Hebert, M. Hide, A. Kaplan, A. Kapp, A.H. Abdul Latiff, P. Mathelier-Fusade, M. Metz, A. Nast, S.S. Saini, M. Sánchez-Borges, P. Schmid-Grendelmeier, F.E.R. Simons, P. Staubach, G. Sussman, E. Toubi, G.A. Vena, B. Wedi, X.J. Zhu, M. Maurer, Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami, Alergologia Polska - Polish Journal of Allergology, 2015, 2, 1, T1

    CrossRef

  30. 30
    Line Kibsgaard, Anna Cecile Lefevre, Mette Deleuran, Christian Vestergaard, A Case Series Study of Eighty-Five Chronic Spontaneous Urticaria Patients Referred to a Tertiary Care Center, Annals of Dermatology, 2014, 26, 1, 73

    CrossRef

  31. 31
    L. Curto-Barredo, J.F. Silvestre, A.M. Giménez-Arnau, Actualización en el tratamiento de la urticaria crónica, Actas Dermo-Sifiliográficas, 2014, 105, 5, 469

    CrossRef

  32. 32
    Meir Paul Pener, Allergy to Locusts and Acridid Grasshoppers: a Review, Journal of Orthoptera Research, 2014, 23, 1, 59

    CrossRef

  33. 33
    Arzu Didem Yalcin, An Overview of the Effects of anti-IgE Therapies, Medical Science Monitor, 2014, 20, 1691

    CrossRef

  34. 34
    Allen P. Kaplan, Todor A. Popov, Biologic agents and the therapy of chronic spontaneous urticaria, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 347

    CrossRef

  35. 35
    A. B. Kay, S. Ying, E. Ardelean, A. Mlynek, H. Kita, P. Clark, M. Maurer, Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria, Clinical & Experimental Allergy, 2014, 44, 8
  36. 36
    Jennifer W Leiding, Douglas Beakes, Stephen C Dreskin, Anete Grumach, Michihiro Hide, Avner Reshef, Massimo Triggiani, Michael A Kaliner, Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions, World Allergy Organization Journal, 2014, 7, 1, 2

    CrossRef

  37. 37
    Magen Eli, Mishal Joseph, Boris Kuznik, Schlesinger Menachem, Chronic idiopathic angioedema: a single center experience, International Journal of Dermatology, 2014, 53, 10
  38. 38
    H. Zhong, Z. Song, W. Chen, H. Li, L. He, T. Gao, H. Fang, Z. Guo, J. Xv, B. Yu, X. Gao, H. Xie, H. Gu, D. Luo, X. Chen, T. Lei, J. Gu, B. Cheng, Y. Duan, A. Xv, X. Zhu, F. Hao, Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study, Allergy, 2014, 69, 3
  39. 39
    Ganesh N. Dakhale, Abhijit T. Shinde, Mohini S. Mahatme, Sachin K. Hiware, Dharmendra B. Mishra, Jayesh I. Mukhi, Anoop M. Salve, Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial, International Journal of Dermatology, 2014, 53, 5
  40. 40
    Ga-Young Ban, Mi-Yea Kim, Hye-Soo Yoo, Dong-Ho Nahm, Young-Min Ye, Yoo-Seob Shin, Hae-Sim Park, Clinical features of elderly chronic urticaria, The Korean Journal of Internal Medicine, 2014, 29, 6, 800

    CrossRef

  41. 41
    R.A. Sabroe, Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria, British Journal of Dermatology, 2014, 171, 1
  42. 42
    Z. Brzoza, W. Grzeszczak, B. Rogala, W. Trautsolt, D. Moczulski, CTLA-4 polymorphism in the pathogenesis of chronic spontaneous autoreactive urticaria, Allergologia et Immunopathologia, 2014, 42, 3, 241

    CrossRef

  43. 43
    Arzu Didem Yalcin, Betul Celik, Saadet Gumuslu, D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment, Expert Opinion on Biological Therapy, 2014, 14, 3, 283

    CrossRef

  44. 44
    Katherine A. Lyseng-Williamson, Desloratadine: a guide to its use in allergic disorders, Drugs & Therapy Perspectives, 2014, 30, 2, 35

    CrossRef

  45. 45
    Karsten Weller, Adriane Groffik, Martin K. Church, Tomasz Hawro, Karoline Krause, Martin Metz, Peter Martus, Thomas B. Casale, Petra Staubach, Marcus Maurer, Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control, Journal of Allergy and Clinical Immunology, 2014, 133, 5, 1365

    CrossRef

  46. 46
    Matt Morgan, Andrew Cooke, Laura Rogers, Beverley Adams-Huet, David A. Khan, Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 5, 601

    CrossRef

  47. 47
    R. Vieira dos Santos, B. Locks Bidese, J. Rabello de Souza, M. Maurer, Effects of omalizumab in a patient with three types of chronic urticaria, British Journal of Dermatology, 2014, 170, 2
  48. 48
    Roy Anthony Orden, Hersha Timble, Sarbjit S. Saini, Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria, Annals of Allergy, Asthma & Immunology, 2014, 112, 1, 64

    CrossRef

  49. 49
    Kong-Sang Wan, Yung-Sen Chang, Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria, Journal of Dermatological Treatment, 2014, 25, 6, 459

    CrossRef

  50. 50
    A.B. Kay, S. Ying, E. Ardelean, A. Mlynek, H. Kita, P. Clark, M. Maurer, Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin, British Journal of Dermatology, 2014, 171, 3
  51. 51
    Johannes Ring, Kirsten Beyer, Tilo Biedermann, Andreas Bircher, Dorothea Duda, Jörg Fischer, Frank Friedrichs, Thomas Fuchs, Uwe Gieler, Thilo Jakob, Ludger Klimek, Lars Lange, Hans F. Merk, Bodo Niggemann, Oliver Pfaar, Bernhard Przybilla, Franziska Ruëff, Ernst Rietschel, Sabine Schnadt, Roland Seifert, Helmut Sitter, Eva-Maria Varga, Margitta Worm, Knut Brockow, Guideline for acute therapy and management of anaphylaxis, Allergo Journal International, 2014, 23, 3, 96

    CrossRef

  52. 52
    Young-Min Ye, Byung Eui Kim, Yoo Seob Shin, Hae-Sim Park, Donald Y.M. Leung, Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria, Annals of Allergy, Asthma & Immunology, 2014, 112, 6, 533

    CrossRef

  53. 53
    Young-Min Ye, Eun-Mi Yang, Hye-Soo Yoo, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park, Increased Level of Basophil CD203c Expression Predicts Severe Chronic Urticaria, Journal of Korean Medical Science, 2014, 29, 1, 43

    CrossRef

  54. 54
    Siyu Yan, Wangqing Chen, Shu Wen, Wu Zhu, Aiyuan Guo, Xiaoping Chen, Chong Zhang, Mingliang Chen, Jianglin Zhang, Juan Su, Yue Zhao, Yijing He, Zhaoqian Liu, Honghao Zhou, Weiqi Zeng, Jie Li, Xiang Chen, Influence of component 5a receptor 1 (C5AR1) −1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria, Journal of Dermatological Science, 2014, 76, 3, 240

    CrossRef

  55. 55
    Johannes Ring, Kirsten Beyer, Tilo Biedermann, Andreas Bircher, Dorothea Duda, Jörg Fischer, Frank Friedrichs, Thomas Fuchs, Uwe Gieler, Thilo Jakob, Ludger Klimek, Lars Lange, Hans F. Merk, Bodo Niggemann, Oliver Pfaar, Bernhard Przybilla, Franziska Ruëff, Ernst Rietschel, Sabine Schnadt, Roland Seifert, Helmut Sitter, Eva-Maria Varga, Margitta Worm, Knut Brockow, Leitlinie zu Akuttherapie und Management der Anaphylaxie, Allergo Journal, 2014, 23, 3, 36

    CrossRef

  56. 56
    Nipun de Silva, Hasitha Damayanthi, Anoja Rajapakse, Chaturaka Rodrigo, Senaka Rajapakse, Leukotriene receptor antagonists for chronic urticaria: a systematic review, Allergy, Asthma & Clinical Immunology, 2014, 10, 1, 24

    CrossRef

  57. 57
    Maria Pedrosa, Alicia Prieto-García, Anna Sala-Cunill, T. Caballero, M. L. Baeza, R. Cabañas, A. Campos, S. Cimbollek, C. Gómez-Traseira, T. González Quevedo, M. Guilarte, J. Jurado-Palomo, T. Lobera, M. C. López-Serrano, C. Marcos, M. Piñero-Saavedra, N. Prior, B. Sáenz de San Pedro, M. Ferrer, J. M. Barceló, A. Daschner, M. Echechipía, M. Garcés, P. Iriarte, I. Jáuregui, M. Lázaro, M. Quiñones, B. Veleiro, O. Villareal, Management of angioedema without urticaria in the emergency department, Annals of Medicine, 2014, 46, 8, 607

    CrossRef

  58. 58
    Katja Woidacki, Ana Claudia Zenclussen, Frank Siebenhaar, Mast Cell-Mediated and Associated Disorders in Pregnancy: A Risky Game with an Uncertain Outcome?, Frontiers in Immunology, 2014, 5,

    CrossRef

  59. You have free access to this content59
    T. Zuberbier, W. Aberer, R. Asero, C. Bindslev-Jensen, Z. Brzoza, G. W. Canonica, M. K. Church, L. F. Ensina, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, J. Hebert, M. Hide, A. Kaplan, A. Kapp, A. H. Abdul Latiff, P. Mathelier-Fusade, M. Metz, S. S. Saini, M. Sánchez-Borges, P. Schmid-Grendelmeier, F. E. R. Simons, P. Staubach, G. Sussman, E. Toubi, G. A. Vena, B. Wedi, X. J. Zhu, A. Nast, M. Maurer, Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria, Allergy, 2014, 69, 7
  60. 60
    C. Grattan, Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study, British Journal of Dermatology, 2014, 171, 1
  61. 61
    M. Staevska, M. Gugutkova, C. Lazarova, T. Kralimarkova, V. Dimitrov, T. Zuberbier, M.K. Church, T.A. Popov, Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial, British Journal of Dermatology, 2014, 171, 1
  62. 62
    Diana Silva, Ignacio Ansotegui, Mário Morais-Almeida, Off-label prescribing for allergic diseases in children, World Allergy Organization Journal, 2014, 7, 1, 4

    CrossRef

  63. 63
    Yankel J. Girshman, Ying Wang, Alan Mendelowitz, Olanzapine for the Treatment of Psychiatric Illness and Urticaria: A Case Report, Psychosomatics, 2014, 55, 6, 735

    CrossRef

  64. 64
    L. Francés, M. Leiva-Salinas, J.F. Silvestre, Omalizumab en el tratamiento de la urticaria crónica, Actas Dermo-Sifiliográficas, 2014, 105, 1, 45

    CrossRef

  65. 65
    L. Francés, M. Leiva-Salinas, J.F. Silvestre, Omalizumab in the Treatment of Chronic Urticaria, Actas Dermo-Sifiliográficas (English Edition), 2014, 105, 1, 45

    CrossRef

  66. 66
    Martin Metz, Tatevik Ohanyan, Martin K. Church, Marcus Maurer, Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis, Journal of Dermatological Science, 2014, 73, 1, 57

    CrossRef

  67. 67
    Teresa Tsakok, George Du Toit, Carsten Flohr, Pediatric Urticaria, Immunology and Allergy Clinics of North America, 2014, 34, 1, 117

    CrossRef

  68. 68
    Marina Abajian, Nicole Schoepke, Sabine Altrichter, Torsten Zuberbier, Marcus Maurer, Physical Urticarias and Cholinergic Urticaria, Immunology and Allergy Clinics of North America, 2014, 34, 1, 73

    CrossRef

  69. 69
    P. Mathelier-Fusade, Place du bilan allergologique dans l’urticaire, Annales de Dermatologie et de Vénéréologie, 2014, 141, S565

    CrossRef

  70. 70
    Gordon Sussman, Jacques Hébert, Carly Barron, Jia Bian, Rose-Marie Caron-Guay, Stéphanie Laflamme, Simon Stern, Real-life experiences with omalizumab for the treatment of chronic urticaria, Annals of Allergy, Asthma & Immunology, 2014, 112, 2, 170

    CrossRef

  71. You have free access to this content71
    M. Jutel, N. G. Papadopoulos, H. Gronlund, H.-J. Hoffman, B. Bohle, P. Hellings, G.-J. Braunsthal, A. Muraro, P. Schmid-Grendelmeier, T. Zuberbier, I. Agache, Recommendations for the allergy management in the primary care, Allergy, 2014, 69, 6
  72. 72
    Madhavi Latha Alasandagutti, Meenakshi Ponnana, Ramya Sivangala, Shruthi Thada, Lavanya Joshi, Hidayath Hussain, Soheb Sadath Ansari, Vijayalakshmi Valluri, Suman Latha Gaddam, Role of IFN-γ and IL-6 Cytokines and Their Association in Determining Susceptibility to Chronic Idiopathic Urticaria, Genetic Testing and Molecular Biomarkers, 2014, 18, 12, 804

    CrossRef

  73. 73
    Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia, Giorgio Walter Canonica, Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data, Clinical Investigation, 2014, 4, 5, 453

    CrossRef

  74. 74
    Second-generation antihistamines are the key to treating chronic urticaria, but other agents may be necessary to treat refractory disease, Drugs & Therapy Perspectives, 2014, 30, 7, 248

    CrossRef

  75. 75
    Ayse Bilge Ozturk, Emek Kocaturk, Erman Ozturk, Successful Treatment of a Bullous Urticaria with Omalizumab, Allergology International, 2014, 63, 3, 495

    CrossRef

  76. 76
    M. Rodríguez-Rodríguez, D. Antolin-Amerigo, J. Barbarroja-Escudero, M.J. Sánchez-González, M. Alvarez-Mon, Successful treatment of severe delayed pressure angio-oedema with omalizumab, Allergologia et Immunopathologia, 2014, 42, 1, 78

    CrossRef

  77. You have free access to this content77
    T. Zuberbier, W. Aberer, R. Asero, C. Bindslev-Jensen, Z. Brzoza, G. W. Canonica, M. K. Church, L. F. Ensina, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, J. Hebert, M. Hide, A. Kaplan, A. Kapp, A. H. Abdul Latiff, P. Mathelier-Fusade, M. Metz, A. Nast, S. S. Saini, M. Sánchez-Borges, P. Schmid-Grendelmeier, F. E. R. Simons, P. Staubach, G. Sussman, E. Toubi, G. A. Vena, B. Wedi, X. J. Zhu, M. Maurer, The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update, Allergy, 2014, 69, 7
  78. 78
    Jenny M Stitt, Stephen C Dreskin, The potential role of omalizumab in the treatment of chronic urticaria, Immunotherapy, 2014, 6, 6, 691

    CrossRef

  79. 79
    Riccardo Asero, Alberto Tedeschi, Massimo Cugno, Treatment of Chronic Urticaria, Immunology and Allergy Clinics of North America, 2014, 34, 1, 105

    CrossRef

  80. 80
    Frank Siebenhaar, Cem Akin, Carsten Bindslev-Jensen, Marcus Maurer, Sigurd Broesby-Olsen, Treatment Strategies in Mastocytosis, Immunology and Allergy Clinics of North America, 2014, 34, 2, 433

    CrossRef

  81. 81
    Nadine Marrouche, Clive Grattan, Update and insights into treatment options for chronic spontaneous urticaria, Expert Review of Clinical Immunology, 2014, 10, 3, 397

    CrossRef

  82. 82
    Anna Belloni Fortina, Elena Fontana, Update on Antihistamine Treatment for Chronic Urticaria in Children, Current Treatment Options in Allergy, 2014, 1, 3, 287

    CrossRef

  83. 83
    L. Curto-Barredo, J.F. Silvestre, A.M. Giménez-Arnau, Update on the Treatment of Chronic Urticaria, Actas Dermo-Sifiliográficas (English Edition), 2014, 105, 5, 469

    CrossRef

  84. 84
    A. Soria, C. Francès, Urticaires : diagnostic, prise en charge et traitement, La Revue de Médecine Interne, 2014, 35, 9, 586

    CrossRef

  85. 85
    A. Du Thanh, Urticaires inductibles et urticaires chroniques spontanées, Annales de Dermatologie et de Vénéréologie, 2014, 141, S570

    CrossRef

  86. 86
    Brigid F. O’Donnell, Urticaria, Immunology and Allergy Clinics of North America, 2014, 34, 1, 89

    CrossRef

  87. 87
    Silvia Garriga-Companys, Moisés Labrador-Horrillo, Urticaria crónica espontánea, Medicina Clínica, 2014, 142, 6, 275

    CrossRef

  88. 88
    Ana Giménez-Arnau, Contact Urticaria Syndrome, 2014,

    CrossRef

  89. 89
    Robin Thurmond, Kayvan Kazerouni, Sandra Chaplan, Andrew Greenspan, Itch, 2014,

    CrossRef

  90. 90
    Garry M. Walsh, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2014,

    CrossRef

  91. 91
    Stefan Wöhrl, Katharina B. Moritz, Andreas Bracher, Gottfried Fischer, Georg Stingl, Robert Loewe, A c-kit Mutation in Exon 18 in Familial Mastocytosis, Journal of Investigative Dermatology, 2013, 133, 3, 839

    CrossRef

  92. 92
    Anna Cecilie Lefévre, Mette Deleuran, Christian Vestergaard, A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria, Annals of Dermatology, 2013, 25, 2, 242

    CrossRef

  93. 93
    Yong Sung Choi, Yong Mean Park, Yeong Ho Rha, Sun Hee Choi, An overview and considerations in prescribing H1-antihistamine, Journal of the Korean Medical Association, 2013, 56, 3, 231

    CrossRef

  94. 94
    L. Bouillet, I. Boccon-Gibod, D. Fagedet, F. Berard, J.-F. Nicolas, Angiœdème récurrent : démarche diagnostique et place de la biologie, Revue Française d'Allergologie, 2013, 53, 6, 528

    CrossRef

  95. 95
    Mario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett, Aspirin-Exacerbated Cutaneous Disease, Immunology and Allergy Clinics of North America, 2013, 33, 2, 251

    CrossRef

  96. 96
    Ignacio Jáuregui, Marta Ferrer, Joan Bartra, Alfonso del Cuvillo, Ignacio Dávila, Javier Montoro, Joaquim Mullol, Joaquín Sastre, Antonio Valero, Bilastine for the treatment of urticaria, Expert Opinion on Pharmacotherapy, 2013, 14, 11, 1537

    CrossRef

  97. 97
    David A. Khan, Bringing Your “A” Game to Urticaria and Angioedema, The Journal of Allergy and Clinical Immunology: In Practice, 2013, 1, 5, 425

    CrossRef

  98. 98
    Martin Metz, Ulrich Wahn, Uwe Gieler, Philippe Stock, Jochen Schmitt, Ulrike Blume-Peytavi, Chronic pruritus associated with dermatologic disease in infancy and childhood: Update from an interdisciplinary group of dermatologists and pediatricians, Pediatric Allergy and Immunology, 2013, 24, 6
  99. 99
    Angelo V. Marzano, Alberto Tedeschi, Claudia Menicanti, Riccardo Asero, Carlo Crosti, Massimo Cugno, Chronic Spontaneous Urticaria: the Emerging Role of Coagulation, Current Dermatology Reports, 2013, 2, 1, 18

    CrossRef

  100. 100
    Eli Magen, Menachem Schlesinger, Israel Hadari, Chronic Urticaria can be Triggered by Eradication of Helicobacter pylori, Helicobacter, 2013, 18, 1
  101. 101
    Sujoy Khan, Anirban Maitra, Pravin Hissaria, Sitesh Roy, Mahesh Padukudru Anand, Nalin Nag, Harpal Singh, Chronic Urticaria: Indian Context—Challenges and Treatment Options, Dermatology Research and Practice, 2013, 2013, 1

    CrossRef

  102. 102
    Eli Magen, Joseph Mishal, Menachem Schlesinger, Clinical and laboratory features of chronic idiopathic urticaria in the elderly, International Journal of Dermatology, 2013, 52, 11
  103. 103
    Songül Bulca, Dilek Bayramgürler, Evren Odyakmaz Demirsoy, Melike Yavuz, Aysun Şikar Aktürk, Nilgün Bilen, Rebiay Kıran, Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers, Journal of Dermatological Treatment, 2013, 24, 6, 473

    CrossRef

  104. 104
    David M. Lang, Fred H. Hsieh, Jonathan A. Bernstein, Contemporary approaches to the diagnosis and management of physical urticaria, Annals of Allergy, Asthma & Immunology, 2013, 111, 4, 235

    CrossRef

  105. 105
    Daranporn Triwongwaranat, Kanokvalai Kulthanan, Leena Chularojanamontri, Samruay Pinkaew, Correlation between plasma D-dimer levels and the severity of patients with chronic urticaria, Asia Pacific Allergy, 2013, 3, 2, 100

    CrossRef

  106. 106
    Sarah Wakelin, Dermatological pharmacology: systemic drugs, Medicine, 2013, 41, 6, 330

    CrossRef

  107. 107
    Marcus Maurer, Diagnostik und Therapie der chronischen Urtikaria – was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet?, Allergo Journal, 2013, 22, 5, 324

    CrossRef

  108. 108
    M. Maurer, M. Magerl, M. Metz, T. Zuberbier, Diagnostik und Therapie der chronischen Urtikaria – Was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet?, Der Hautarzt, 2013, 64, 9, 638

    CrossRef

  109. 109
    Alvaro Daschner, Virginia Fernández-Fígares, Ana Valls, Consolación de Frutos, Marta Rodero, Florencio M. Ubeira, Carmen Cuéllar, Different Fish-Eating Habits and Cytokine Production in Chronic Urticaria with and without Sensitization against the Fish-Parasite Anisakis simplex, Allergology International, 2013, 62, 2, 191

    CrossRef

  110. 110
    Moises Labrador-Horrillo, Antonio Valero, Manuel Velasco, Ignacio Jáuregui, Joaquin Sastre, Joan Bartra, Juan Francisco Silvestre, Javier Ortiz de Frutos, Ana Gimenez-Arnau, Marta Ferrer, Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice, Expert Opinion on Biological Therapy, 2013, 13, 9, 1225

    CrossRef

  111. 111
    Cheol Min Shin, Extra-Intestinal Manifestation ofHelicobacter pyloriInfection: Allergic Diseases Including Asthma, Atopy and Idiopathic Urticaria, Korean Journal of Medicine, 2013, 84, 6, 774

    CrossRef

  112. 112
    A. Pressler, M. Grosber, M. Halle, J. Ring, K. Brockow, Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema, Clinical and Experimental Dermatology, 2013, 38, 2
  113. 113
    Martin Metz, Clemens Krull, Marcus Maurer, Histamine, TNF, C5a, IL-6, -9, -18, -31, -33, TSLP, Neopterin, and VEGF are not elevated in chronic spontaneous urticaria, Journal of Dermatological Science, 2013, 70, 3, 222

    CrossRef

  114. 114
    Christine Hahjin Song, Simon Stern, Mohana Giruparajah, Noam Berlin, Gordon L. Sussman, Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria, Annals of Allergy, Asthma & Immunology, 2013, 110, 2, 113

    CrossRef

  115. 115
    K. Weller, K. Viehmann, M. Bräutigam, K. Krause, F. Siebenhaar, T. Zuberbier, M. Maurer, Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross-sectional physician-based survey study, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 1
  116. 116
    P. Staubach, A. Groffik, Nützliche Instrumente für die Dokumentation bei Urtikaria, Der Hautarzt, 2013, 64, 9, 650

    CrossRef

  117. 117
    Omalizumab for Chronic Urticaria, New England Journal of Medicine, 2013, 368, 26, 2527

    CrossRef

  118. 118
    Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh, Sarbjit Saini, Clive Grattan, Ana Gimenéz-Arnau, Sunil Agarwal, Ramona Doyle, Janice Canvin, Allen Kaplan, Thomas Casale, Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria, New England Journal of Medicine, 2013, 368, 10, 924

    CrossRef

  119. 119
    Miquel Armengot-Carbo, Manuel Velasco-Pastor, Beatriz Rodrigo-Nicolas, Virginia Pont-Sanjuan, Esther Quecedo-Estebanez, Enrique Gimeno-Carpio, Omalizumab in chronic urticaria: a retrospective series of 15 cases, Dermatologic Therapy, 2013, 26, 3
  120. 120
    Allen Kaplan, Dennis Ledford, Mark Ashby, Janice Canvin, James L. Zazzali, Edward Conner, Joachim Veith, Nikhil Kamath, Petra Staubach, Thilo Jakob, Robert G. Stirling, Piotr Kuna, William Berger, Marcus Maurer, Karin Rosén, Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy, Journal of Allergy and Clinical Immunology, 2013, 132, 1, 101

    CrossRef

  121. 121
    Michael Makris, Marcus Maurer, Torsten Zuberbier, Pharmacotherapy of chronic spontaneous urticaria, Expert Opinion on Pharmacotherapy, 2013, 14, 18, 2511

    CrossRef

  122. 122
    E. Magen, J. Mishal, Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria, Clinical and Experimental Dermatology, 2013, 38, 1
  123. 123
    M. Maurer, M. Magerl, M. Metz, F. Siebenhaar, K. Weller, K. Krause, Practical algorithm for diagnosing patients with recurrent wheals or angioedema, Allergy, 2013, 68, 6
  124. 124
    Audrey Nosbaum, Marion Braire-Bourrel, Rolande Dubost, Amélie Faudel, Stéphanie Parat, Jean-François Nicolas, Frédéric Bérard, Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema, Annals of Allergy, Asthma & Immunology, 2013, 110, 4, 263

    CrossRef

  125. 125
    Mohamed Kamel-Sabry, Mohamed Nazmy-Farres, Nermine Abdelnour-Melek, Naglaa Ahmed-Arafa, Annie Arek-Ohanessian, Prolactin and Dehydroepiandrosterone Sulfate: Are They Related to the Severity of Chronic Urticaria?, Archives of Medical Research, 2013, 44, 1, 21

    CrossRef

  126. 126
    M. Ben-Shoshan, I. Blinderman, A. Raz, Psychosocial factors and chronic spontaneous urticaria: a systematic review, Allergy, 2013, 68, 2
  127. 127
    Yumi Ogawa, Yuko Ichinokawa, Midori Hiruma, Yuko Machida, Naoko Funakushi, Hiroko Sadamasa, Masataro Hiruma, Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria, Journal of Dermatological Treatment, 2013, 24, 6, 463

    CrossRef

  128. You have free access to this content128
    Marcus Maurer, Markus Magerl, Martin Metz, Torsten Zuberbier, Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2013, 11, 10
  129. 129
    Eustachio Nettis, Pantalea Delle Donne, Elisabetta Di leo, Gian Franco Calogiuri, Antonio Ferrannini, Angelo Vacca, Rupatadine for the treatment of urticaria, Expert Opinion on Pharmacotherapy, 2013, 14, 13, 1807

    CrossRef

  130. 130
    K. Weller, N. Schoepke, K. Krause, E. Ardelean, M. Bräutigam, M. Maurer, Selected urticaria patients benefit from a referral to tertiary care centres – results of an expert survey, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 1
  131. 131
    S. Comert, E. Celebioglu, G. Karakaya, A.F. Kalyoncu, The general characteristics of acute urticaria attacks and the factors predictive of progression to chronic urticaria, Allergologia et Immunopathologia, 2013, 41, 4, 239

    CrossRef

  132. 132
    J. M. Igea, The history of the idea of allergy, Allergy, 2013, 68, 8
  133. 133
    The management of paediatric allergy, Current Opinion in Allergy and Clinical Immunology, 2013, 13, S1

    CrossRef

  134. 134
    Suh-Young Lee, Woo-Jung Song, Jae-Woo Jung, Heung-Woo Park, Sang-Heon Cho, Kyung-Up Min, Hye-Ryun Kang, Thyroid autoantibodies and the prognosis of chronic idiopathic urticaria, Allergy Asthma & Respiratory Disease, 2013, 1, 2, 151

    CrossRef

  135. 135
    Riccardo Asero, Alberto Tedeschi, Massimo Cugno, Treatment of Refractory Chronic Urticaria: Current and Future Therapeutic Options, American Journal of Clinical Dermatology, 2013, 14, 6, 481

    CrossRef

  136. 136
    K. Krause, A. Spohr, T. Zuberbier, M. K. Church, M. Maurer, Up-dosing with bilastine results in improved effectiveness in cold contact urticaria, Allergy, 2013, 68, 7
  137. 137
    D. Wieczorek, J. Langhorst, A. Kapp, B. Wedi, Urtikaria, Der Hautarzt, 2013, 64, 9, 644

    CrossRef

  138. 138
    B. Wedi, D. Wieczorek, U. Raap, A. Kapp, Urtikaria … und die Therapie versagt!, Der Hautarzt, 2013, 64, 9, 656

    CrossRef

  139. 139
    D. Linn Holness, Victoria H. Arrandale, C.G. Toby Mathias, Asthma in the Workplace, 2013,

    CrossRef

  140. 140
    Torsten Zuberbier, A Summary of the New International EAACI/GA2LEN/EDF/WAO Guidelines in Urticaria, World Allergy Organization Journal, 2012, 5, S1

    CrossRef

  141. 141
    Ignacio Jáuregui, Eduardo García-Lirio, Ana Ma Soriano, Pedro M Gamboa, Ignacio Antépara, An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria, Expert Review of Clinical Immunology, 2012, 8, 1, 33

    CrossRef

  142. 142
    Mahmoud A. Abdallah, Marwa Elzamk, Mohamed A. Sallam, Autologous serum injection versus autologous blood in the treatment of chronic autoreactive urticaria, Journal of the Egyptian Womenʼs Dermatologic Society, 2012, 9, 1, 26

    CrossRef

  143. 143
    Natalie J. Carter, Bilastine, Drugs, 2012, 72, 9, 1257

    CrossRef

  144. 144
    Katherine A. Lyseng-Williamson, Natalie J. Carter, Bilastine: a guide to its use in the treatment of symptomatic allergic rhinoconjunctivitis and urticaria, Drugs & Therapy Perspectives, 2012, 28, 11, 1

    CrossRef

  145. 145
    Timothy D. Trojan, David A. Khan, Calcineurin inhibitors in chronic urticaria, Current Opinion in Allergy and Clinical Immunology, 2012, 12, 4, 412

    CrossRef

  146. 146
    Torsten Zuberbier, Chronic Urticaria, Current Allergy and Asthma Reports, 2012, 12, 4, 267

    CrossRef

  147. 147
    Sujoy Khan, Chronic urticaria and use of statins, Asia Pacific Allergy, 2012, 2, 3, 227

    CrossRef

  148. 148
    Y.-M. Ye, J.-W. Park, S.-H. Kim, J.-H. Choi, G.-Y. Hur, H.-Y. Lee, E.-H. Lee, H.-S. Park, Clinical evaluation of the computerized Chronic Urticaria-Specific Quality of Life questionnaire in Korean patients with chronic urticaria, Clinical and Experimental Dermatology, 2012, 37, 7
  149. 149
    M. Magerl, D. Pisarevskaja, P. Staubach, P. Martus, M.K. Church, M. Maurer, Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H1-antihistamine dose escalation, British Journal of Dermatology, 2012, 166, 5
  150. 150
    Inga Adamska, Mieczysława Czerwionka-Szaflarska, Agnieszka Sala-Sacharczuk, Czy jest miejsce w pediatrii dla leków antyhistaminowych I generacji?, Pediatria Polska, 2012, 87, 5, 516

    CrossRef

  151. 151
    Mario Sánchez-Borges, Riccardo Asero, Ignacio J. Ansotegui, Ilaria Baiardini, Jonathan A Bernstein, G Walter Canonica, Richard Gower, David A Kahn, Allen P Kaplan, Connie Katelaris, Marcus Maurer, Hae Sim Park, Paul Potter, Sarbjit Saini, Paolo Tassinari, Alberto Tedeschi, Young Min Ye, Torsten Zuberbier, Diagnosis and Treatment of Urticaria and Angioedema, World Allergy Organization Journal, 2012, 5, 11, 125

    CrossRef

  152. 152
    Young-Hee Nam, Joo-Hee Kim, Hyun Jung Jin, Eui-Kyung Hwang, Yoo-Seob Shin, Young-Min Ye, Hae-Sim Park, Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria, Allergy, Asthma & Immunology Research, 2012, 4, 6, 357

    CrossRef

  153. 153
    Jean Bousquet, Ignacio Ansótegui, G. Walter Canonica, Torsten Zuberbier, Carlos E. Baena-Cagnani, Claus Bachert, Alvaro A. Cruz, Sandra N. González, Piotr Kuna, Mario Morais-Almeida, Joaquim Mullol, Dermot P. Ryan, Mario Sánchez-Borges, Román Valiente, Martin K. Church, Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review, Current Medical Research and Opinion, 2012, 28, 1, 131

    CrossRef

  154. 154
    Ivan Pavić, Iva Hojsak, Jasna Čepin-Bogović, Evidence-Based Management of Chronic Urticaria in Children, Pediatric Allergy, Immunology, and Pulmonology, 2012, 25, 4, 198

    CrossRef

  155. 155
    M. K. Church, M. Maurer, H1-antihistamines and urticaria: how can we predict the best drug for our patient?, Clinical & Experimental Allergy, 2012, 42, 10
  156. 156
    K. Krause, C. E. Grattan, C. Bindslev-Jensen, M. Gattorno, T. Kallinich, H. D. Koning, H. J. Lachmann, D. Lipsker, A. A. Navarini, A. Simon, C. Traidl-Hoffmann, M. Maurer, How not to miss autoinflammatory diseases masquerading as urticaria, Allergy, 2012, 67, 12
  157. 157
    C.-R. Shi, Y.-P. Li, Y.-J. Luo, C.-B. Shi, X. Yan, K.-H. Yang, K. Yi, IgE-mediated allergy: a rare cause of chronic spontaneous urticarial with allergen-specific immunotherapy as treatment option – a systematic review with meta-analysis from China, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 5
  158. 158
    Michihiro Hide, Takaaki Hiragun, Japanese Guidelines for Diagnosis and Treatment of Urticaria in Comparison with Other Countries, Allergology International, 2012, 61, 4, 517

    CrossRef

  159. 159
    Shinji NODA, Yoshihide ASANO, Shinichi SATO, Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment, The Journal of Dermatology, 2012, 39, 5
  160. 160
    Steven K.W. Chow, Management of chronic urticaria in Asia: 2010 AADV consensus guidelines, Asia Pacific Allergy, 2012, 2, 2, 149

    CrossRef

  161. 161
    J. Sanchez, R. Ramirez, S. Diez, S. Sus, A. Echenique, M. Olivares, R. Cardona, Omalizumab beyond asthma, Allergologia et Immunopathologia, 2012, 40, 5, 306

    CrossRef

  162. 162
    Martin Metz, Marcus Maurer, Omalizumab in chronic urticaria, Current Opinion in Allergy and Clinical Immunology, 2012, 12, 4, 406

    CrossRef

  163. You have free access to this content163
    Suna BÜYÜKÖZTÜRK, Aslı GELINCIK, Mustafa DEMIRTÜRK, Emek KOCATURK, Bahattin ÇOLAKOĞLU, Murat DAL, Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey, The Journal of Dermatology, 2012, 39, 5
  164. 164
    María del Carmen Vennera, César Picado, Patologías mediadas por la inmunoglobulina E: de la inmunoglobulina E al omalizumab, Inmunología, 2012, 31, 4, 119

    CrossRef

  165. 165
    T. Zuberbier, Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 1
  166. 166
    Marina Abajian, Agnieszka Młynek, Marcus Maurer, Physical Urticaria, Current Allergy and Asthma Reports, 2012, 12, 4, 281

    CrossRef

  167. 167
    Ozgur Kartal, Mustafa Gulec, Zafer Caliskaner, Oral Nevruz, Turker Cetin, Osman Sener, Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis, Allergy, Asthma & Immunology Research, 2012, 4, 4, 245

    CrossRef

  168. 168
    María Luisa Lucero, Joseba K. Arteche, E. W. Sommer, Agustín Casadesus, Preclinical toxicity profile of oral bilastine, Drug and Chemical Toxicology, 2012, 35, sup1, 25

    CrossRef

  169. 169
    M.-L. Hsu, L.-F. Li, Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria, British Journal of Dermatology, 2012, 166, 4
  170. 170
    A. Nosbaum, F. Augey, J.-F. Nicolas, F. Bérard, Prise en charge des urticaires chroniques rebelles aux traitements : associer médicaments et éducation des patients, Revue Française d'Allergologie, 2012, 52, 5, 375

    CrossRef

  171. 171
    U. Raap, A. Kapp, U. Darsow, Psychopharmakatherapie bei Pruritus, Der Hautarzt, 2012, 63, 7, 553

    CrossRef

  172. 172
    Susan Leech, Recurrent urticaria, Paediatrics and Child Health, 2012, 22, 7, 281

    CrossRef

  173. 173
    K. Yanai, B. Rogala, K. Chugh, E. Paraskakis, A.N. Pampura, R. Boev, Safety considerations in the management of allergic diseases: focus on antihistamines, Current Medical Research and Opinion, 2012, 28, 4, 623

    CrossRef

  174. 174
    Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper, International Archives of Allergy and Immunology, 2012, 158, 3, 216

    CrossRef

  175. 175
    Travis T Wager, Jennifer L Liras, Scot Mente, Patrick Trapa, Strategies to minimize CNS toxicity:in vitrohigh-throughput assays and computational modeling, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 5, 531

    CrossRef

  176. 176
    G. Calado, G. Loureiro, D. Machado, B. Tavares, C. Ribeiro, C. Pereira, A.S. Luís, Streptococcal tonsillitis as a cause of urticaria, Allergologia et Immunopathologia, 2012, 40, 6, 341

    CrossRef

  177. 177
    Eli Magen, Joseph Mishal, The effect of l-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis, International Journal of Dermatology, 2012, 51, 1
  178. 178
    Ravi K. Viswanathan, Mark J. Biagtan, Sameer K. Mathur, The role of autoimmune testing in chronic idiopathic urticaria, Annals of Allergy, Asthma & Immunology, 2012, 108, 5, 337

    CrossRef

  179. 179
    C. Grattan, The urticarias: pathophysiology and management, Clinical Medicine, 2012, 12, 2, 164

    CrossRef

  180. 180
    Allen P. Kaplan, Treatment of Chronic Spontaneous Urticaria, Allergy, Asthma & Immunology Research, 2012, 4, 6, 326

    CrossRef

  181. 181
    I. Boccon-gibod, Urticaire/angioedème histaminique ou bradykinique ?, Revue Française d'Allergologie, 2012, 52, 4, 327

    CrossRef

  182. 182
    Jean-Paul Ortonne, Urticaria and its subtypes: The role of second-generation antihistamines, European Journal of Internal Medicine, 2012, 23, 1, 26

    CrossRef

  183. 183
    Simon Francis Thomsen, Sophie van der Sluis, Kirsten Ohm Kyvik, Vibeke Backer, Urticaria in Monozygotic and Dizygotic Twins, Journal of Allergy, 2012, 2012, 1

    CrossRef

  184. 184
    Chi-Shin Wu, Wen-Yi Shau, Hung-Yu Chan, Yen-Chieh Lee, Yun-Ju Lai, Mei-Shu Lai, Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009, Pharmacoepidemiology and Drug Safety, 2012, 21, 9
  185. 185
    Timothy Craig, Emel Aygören Pürsün, Konrad Bork, Tom Bowen, Henrik Boysen, Henriette Farkas, Anete Grumach, Constance H. Katelaris, Richard Lockey, Hilary Longhurst, William Lumry, Markus Magerl, Immaculada Martinez-Saguer, Bruce Ritchie, Alexander Nast, Ruby Pawankar, Bruce Zuraw, Marcus Maurer, WAO Guideline for the Management of Hereditary Angioedema, World Allergy Organization Journal, 2012, 5, 12, 182

    CrossRef

  186. 186
    Ana Gimenez-Arnau, Dermatotoxicology, 2012,

    CrossRef

  187. 187
    Garry M. Walsh, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2012,

    CrossRef

  188. 188
    Marcus Maurer, Clive EH Grattan, Bruce L Zuraw, Allergy, 2012,

    CrossRef

  189. 189
    Klinische Immunologie, 2012,

    CrossRef

  190. 190
    Martin K Church, Thomas B Casale, Allergy, 2012,

    CrossRef

  191. 191
    Sarbjit Saini, Karin E. Rosen, Hsin-Ju Hsieh, Dennis A. Wong, Edward Conner, Allen Kaplan, Sheldon Spector, Marcus Maurer, A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria, Journal of Allergy and Clinical Immunology, 2011, 128, 3, 567

    CrossRef

  192. 192
    Mitja Kosnik, Tjasa Subic, Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria, Respiratory Medicine, 2011, 105, S84

    CrossRef

  193. 193
    Ömür Aydin, Gülfem Çelik, Zeynep Misirligil, Antihistamines in chronic urticaria: threat or treat?, Allergologia et Immunopathologia, 2011, 39, 5, 307

    CrossRef

  194. 194
    G. Walter Canonica, Michael Blaiss, Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: A Review of the Evidence, World Allergy Organization Journal, 2011, 4, 2, 46

    CrossRef

  195. 195
    Fredrik Thorn, Halvor Celius, Tone Ødegård, Randeep Mandla, Erik Hexeberg, Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway, Clinical and Molecular Allergy, 2011, 9, 1, 5

    CrossRef

  196. 196
    Todor A. Popov, Challenges in the Management of Chronic Urticaria, World Allergy Organization Journal, 2011, 4, Supplement, S28

    CrossRef

  197. 197
    Hsing-Chuan Lee, Jin-Bon Hong, Chia-Yu Chu, Chronic Idiopathic Urticaria in Taiwan: A Clinical Study of Demographics, Aggravating Factors, Laboratory Findings, Serum Autoreactivity and Treatment Response, Journal of the Formosan Medical Association, 2011, 110, 3, 175

    CrossRef

  198. 198
    Martin K. Church, Karsten Weller, Philippe Stock, Marcus Maurer, Chronic spontaneous urticaria in children: Itching for insight, Pediatric Allergy and Immunology, 2011, 22, 1-Part-I
  199. 199
    Jean-Paul Ortonne, Chronic urticaria: a comparison of management guidelines, Expert Opinion on Pharmacotherapy, 2011, 12, 17, 2683

    CrossRef

  200. 200
    Mark J. Biagtan, Ravi K. Viswanathan, Michael D. Evans, Sameer K. Mathur, Clinical utility of the Chronic Urticaria Index, Journal of Allergy and Clinical Immunology, 2011, 127, 6, 1626

    CrossRef

  201. 201
    Heidi Olze, Torsten Zuberbier, Comorbidities between nose and skin allergy, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 5, 457

    CrossRef

  202. 202
    Martin K. Church, Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans, Inflammation Research, 2011, 60, 12, 1107

    CrossRef

  203. 203
    G. A. C. Dias, G. V. Pires, S. O. R. Valle, A. T. França, J. A. Papi, S. D. Dortas, S. A. P. Levy, I. Baiardini, G. W. Canonica, Cross-cultural adaptation of the Brazilian–Portuguese version of the chronic urticaria quality-of-life questionnaire – CU-Q2oL, Allergy, 2011, 66, 11
  204. 204
    Sonja Alexandra Grundmann, Sabine Kiefer, Thomas Anton Luger, Randolf Brehler, Delayed pressure urticaria – Dapsone heading for first-line therapy?, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2011, 9, 11
  205. 205
    Ilaria Baiardini, Fulvio Braido, Omar Fassio, Rosaria Calia, Giorgio Walter Canonica, Antonino Romano, Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire, Annals of Allergy, Asthma & Immunology, 2011, 106, 4, 330

    CrossRef

  206. 206
    Marcus Maurer, Carsten Bindslev-Jensen, Nicole Schoepke, Torsten Zuberbier, Effects of a Novel GA2LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-Arabia, World Allergy Organization Journal, 2011, 4, 2, 44

    CrossRef

  207. 207
    Marcus Maurer, Sabine Altrichter, Thomas Bieber, Tilo Biedermann, Matthias Bräutigam, Stefan Seyfried, Randolf Brehler, Jürgen Grabbe, Nicolas Hunzelmann, Thilo Jakob, Andreas Jung, Jörg Kleine-Tebbe, Martin Mempel, Michael Meurer, Kristian Reich, Franziska Ruëff, Knut Schäkel, Kaushik Sengupta, Christian Sieder, Jan C. Simon, Bettina Wedi, Torsten Zuberbier, Vera Mahler, Petra Staubach, Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase, Journal of Allergy and Clinical Immunology, 2011, 128, 1, 202

    CrossRef

  208. 208
    Kristine B. Zitelli, Kelly M. Cordoro, Evidence-Based Evaluation and Management of Chronic Urticaria in Children, Pediatric Dermatology, 2011, 28, 6
  209. 209
    F. Estelle R. Simons, Keith J. Simons, Histamine and H1-antihistamines: Celebrating a century of progress, Journal of Allergy and Clinical Immunology, 2011, 128, 6, 1139

    CrossRef

  210. 210
    M. L. Kowalski, J. S. Makowska, M. Blanca, S. Bavbek, G. Bochenek, J. Bousquet, P. Bousquet, G. Celik, P. Demoly, E. R. Gomes, E. Niżankowska-Mogilnicka, A. Romano, M. Sanchez-Borges, M. Sanz, M. J. Torres, A. De Weck, A. Szczeklik, K. Brockow, Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA, Allergy, 2011, 66, 7
  211. 211
    F. Bossi, B. Frossi, O. Radillo, M. Cugno, A. Tedeschi, P. Riboldi, R. Asero, F. Tedesco, C. Pucillo, Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation, Allergy, 2011, 66, 12
  212. 212
    A. Groffik, H. Mitzel-Kaoukhov, M. Magerl, M. Maurer, P. Staubach, Omalizumab – an effective and safe treatment of therapy-resistant chronic spontaneous urticaria, Allergy, 2011, 66, 2
  213. 213
    Ulrike Raap, Sonja Ständer, Martin Metz, Pathophysiology of itch and new treatments, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 5, 420

    CrossRef

  214. 214
    Marta Ferrer, Pharmacokinetic evaluation of levocetirizine, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 8, 1035

    CrossRef

  215. 215
    N. Silpa-archa, K. Kulthanan, S. Pinkaew, Physical urticaria: prevalence, type and natural course in a tropical country, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 10
  216. 216
    Kazuhiko Yanai, Dongying Zhang, Manabu Tashiro, Takeo Yoshikawa, Fumito Naganuma, Ryuichi Harada, Tadaho Nakamura, Katsuhiko Shibuya, Nobuyuki Okamura, Positron emission tomography evaluation of sedative properties of antihistamines, Expert Opinion on Drug Safety, 2011, 10, 4, 613

    CrossRef

  217. 217
    F. Augey, J.-F. Nicolas, M.-S. Doutre, E. Amsler, P. Mathelier-Fusade, C. Lambert, C. Martinage, A. Nosbaum, Pourquoi un groupe « urticaire » au sein de la Société française de dermatologie ?, Annales de Dermatologie et de Vénéréologie, 2011, 138, 4, 281

    CrossRef

  218. 218
    Martin Metz, Sonja Grundmann, Sonja Ständer, Pruritus: an overview of current concepts, Veterinary Dermatology, 2011, 22, 2
  219. 219
    I. Baiardini, F. Braido, C. Bindslev-Jensen, P. J. Bousquet, Z. Brzoza, G. W. Canonica, E. Compalati, A. Fiocchi, W. Fokkens, R. Gerth van Wijk, A. Giménez-Arnau, K. Godse, C. Grattan, J. J. Grob, S. La Grutta, D. Kalogeromitros, E. Kocatürk, C. Lombardi, A. Mota-Pinto, E. Ridolo, S. S. Saini, M. Sanchez-Borges, G. E. Senna, I. Terreehorst, A. Todo Bom, E. Toubi, J. Bousquet, T. Zuberbier, M. Maurer, Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper, Allergy, 2011, 66, 7
  220. 220
    Martin Metz, Marcus Maurer, Rupatadine for the treatment of allergic rhinitis and urticaria, Expert Review of Clinical Immunology, 2011, 7, 1, 15

    CrossRef

  221. 221
    Martin K Church, Safety and efficacy of bilastine: a new H1-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria, Expert Opinion on Drug Safety, 2011, 10, 5, 779

    CrossRef

  222. 222
    Sayuri Toda, Shunsuke Takahagi, Shoji Mihara, Michihiro Hide, Six Cases of Antihistamine-Resistant Dermographic Urticaria Treated with Oral Ciclosporin, Allergology International, 2011, 60, 4, 547

    CrossRef

  223. 223
    M.-S. Doutre, Traitement de l’urticaire chronique : quoi de neuf ?, Revue Française d'Allergologie, 2011, 51, 3, 134

    CrossRef

  224. 224
    Torsten Zuberbier, Jean Bousquet, Giorgio Walter Canonica, Anca-Mirela Chiriac, Une nouvelle impulsion dans le traitement des allergies, Revue Française d'Allergologie, 2011, 51, 8, H8

    CrossRef

  225. 225
    M. Maurer, K. Weller, C. Bindslev-Jensen, A. Giménez-Arnau, P. J. Bousquet, J. Bousquet, G. W. Canonica, M. K. Church, K. V. Godse, C. E. H. Grattan, M. W. Greaves, M. Hide, D. Kalogeromitros, A. P. Kaplan, S. S. Saini, X. J. Zhu, T. Zuberbier, Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report, Allergy, 2011, 66, 3
  226. 226
    F. Augey, A. Nosbaum, B. Ben-Said, F. Bérard, J.-F. Nicolas, Urticaire chronique et corticodépendance : les corticoïdes n’ont pas de place dans le traitement de l’urticaire, Annales de Dermatologie et de Vénéréologie, 2011, 138, 1, 3

    CrossRef

  227. 227
    E. Amsler, A. Nosbaum, Urticaire chronique et corticothérapie générale, les liaisons dangereuses, Annales françaises de médecine d'urgence, 2011, 1, 5, 303

    CrossRef

  228. 228
    Amin Kanani, Robert Schellenberg, Richard Warrington, Urticaria and angioedema, Allergy, Asthma & Clinical Immunology, 2011, 7, Suppl 1, S9

    CrossRef

  229. 229
    Sara Axelrod, Mark Davis-Lorton, Urticaria and Angioedema, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 5
  230. 230
    Allen P. Kaplan, What to Do With Refractory Urticaria Patients, Current Allergy and Asthma Reports, 2011, 11, 3, 189

    CrossRef

  231. 231
    Ticha Limsuwan, Pascal Demoly, Acute Symptoms of Drug Hypersensitivity (Urticaria, Angioedema, Anaphylaxis, Anaphylactic Shock), Medical Clinics of North America, 2010, 94, 4, 691

    CrossRef

  232. 232
    R. Treudler, Allergische Erkrankungen bei Schwangeren, Der Hautarzt, 2010, 61, 12, 1027

    CrossRef

  233. 233
    G Ricci, A Giannetti, T Belotti, A Dondi, B Bendandi, F Cipriani, M Masi, Allergy is not the main trigger of urticaria in children referred to the emergency room, Journal of the European Academy of Dermatology and Venereology, 2010, 24, 11
  234. You have free access to this content234
    C. Bachert, P. Kuna, T. Zuberbier, Bilastine in allergic rhinoconjunctivitis and urticaria, Allergy, 2010, 65,
  235. 235
    M Metz, S Ständer, Chronic pruritus – pathogenesis, clinical aspects and treatment, Journal of the European Academy of Dermatology and Venereology, 2010, 24, 11
  236. 236
    Susan D. Mathias, Stephen C. Dreskin, Allen Kaplan, Sarbjit S. Saini, Sheldon Spector, Karin E. Rosén, Development of a daily diary for patients with chronic idiopathic urticaria, Annals of Allergy, Asthma & Immunology, 2010, 105, 2, 142

    CrossRef

  237. 237
    Sanmartín Verónica Novell, Lluís Marqués Amat, Josep Manel Casanova Seuma, Diagnóstico y tratamiento de la urticaria, FMC - Formación Médica Continuada en Atención Primaria, 2010, 17, 5, 292

    CrossRef

  238. 238
    U. Bullerkotte, D. Wieczorek, A. Kapp, B. Wedi, Effective treatment of refractory severe heat urticaria with omalizumab, Allergy, 2010, 65, 7
  239. 239
    Markus Magerl, Petra Staubach, Sabine Altrichter, Elena Ardelean, Karoline Krause, Martin Metz, Karsten Weller, Marcus Maurer, Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab, Journal of Allergy and Clinical Immunology, 2010, 126, 3, 665

    CrossRef

  240. 240
    M.K. Church, Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males, British Journal of Dermatology, 2010, 163, 6
  241. 241
    T. Zuberbier, M. Balke, M. Worm, G. Edenharter, M. Maurer, Epidemiology of urticaria: a representative cross-sectional population survey, Clinical and Experimental Dermatology, 2010, 35, 8
  242. 242
    Mario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett, Luis González-Aveledo, Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update, Pharmaceuticals, 2010, 3, 1, 10

    CrossRef

  243. 243
    B. Wedi, U. Raap, D. Wieczorek, A. Kapp, Infektfokus und chronische spontane Urtikaria, Der Hautarzt, 2010, 61, 9, 758

    CrossRef

  244. 244
    K. Krause, F. Degener, S. Altrichter, E. Ardelean, D. Kalogeromitros, M. Magerl, M. Metz, F. Siebenhaar, K. Weller, M. Maurer, Kälteinduzierte Quaddeln und Angioödeme, Der Hautarzt, 2010, 61, 9, 743

    CrossRef

  245. 245
    Jean-Jacques Grob, Serge Boulinguez, Les recommandations dans l’urticaire, Annales de Dermatologie et de Vénéréologie, 2010, 137, 5, H19

    CrossRef

  246. 246
    Karoline Krause, Torsten Zuberbier, Marcus Maurer, Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria, Current Allergy and Asthma Reports, 2010, 10, 4, 243

    CrossRef

  247. 247
    Mario Sánchez-Borges, NSAID Hypersensitivity (Respiratory, Cutaneous, and Generalized Anaphylactic Symptoms), Medical Clinics of North America, 2010, 94, 4, 853

    CrossRef

  248. 248
    H. Korkmaz, S. Eigelshoven, B. Homey, Omalizumab bei therapierefraktärer chronischer Urtikaria mit Angioödem, Der Hautarzt, 2010, 61, 10, 828

    CrossRef

  249. 249
    Katherine A. Lyseng-Williamson, Oral Bepotastine, Drugs, 2010, 70, 12, 1579

    CrossRef

  250. 250
    A. Nosbaum, F. Augey, J.-F. Nicolas, F. Bérard, Physiopathologie de l’urticaire et approches thérapeutiques, La Revue de Médecine Interne, 2010, 31, S18

    CrossRef

  251. 251
    U. Raap, A. Kapp, B. Wedi, S. Ständer, Pruritus bei Urtikaria, Der Hautarzt, 2010, 61, 9, 737

    CrossRef

  252. 252
    Guy W Scadding, Glenis K Scadding, Recent advances in antileukotriene therapy, Current Opinion in Allergy and Clinical Immunology, 2010, 10, 4, 370

    CrossRef

  253. You have free access to this content253
    M. K. Church, M. Maurer, F. E. R. Simons, C. Bindslev-Jensen, P. Van Cauwenberge, J. Bousquet, S. T. Holgate, T. Zuberbier, Risk of first-generation H1-antihistamines: a GA2LEN position paper, Allergy, 2010, 65, 4
  254. 254
    Martin Metz, Elisabeth Scholz, Marta Ferrán, Iñaki Izquierdo, Ana Giménez-Arnau, Marcus Maurer, Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria, Annals of Allergy, Asthma & Immunology, 2010, 104, 1, 86

    CrossRef

  255. 255
    Eustachio Nettis, Maddalena D'Erasmo, Elisabetta Di Leo, Gianfranco Calogiuri, Vincenzo Montinaro, Antonio Ferrannini, Angelo Vacca, The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field, Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  256. 256
    M. Maurer, S. Altrichter, E. Ardelean, K. Krause, M. Magerl, M. Metz, F. Siebenhaar, K. Weller, T. Zuberbier, Therapeutische Alternativen bei Antihistamintherapie-refraktärer Urtikaria, Der Hautarzt, 2010, 61, 9, 765

    CrossRef

  257. 257
    Lucija Kröpfl, Marcus Maurer, Torsten Zuberbier, Treatment strategies in urticaria, Expert Opinion on Pharmacotherapy, 2010, 11, 9, 1445

    CrossRef

  258. 258
    M.-S. Doutre, Urticaire et auto-immunité, Revue Française d'Allergologie, 2010, 50, 5, 456

    CrossRef

  259. 259
    A.B. Alexandroff, K.E. Harman, Urticaria: an evidence-based update. Conference report, British Journal of Dermatology, 2010, 163, 2
  260. 260
    Torsten Schäfer, Acute Urticaria,
  261. 261
    Zbys Fedorowicz, Esther J van Zuuren, Nianfang Hu, Histamine H2-receptor antagonists for urticaria, The Cochrane Library,
  262. 262
    JingWen Deng, Chuanjian Lu, Ching-Chi Chi, Zehui He, Jingjie Yu, Xin-Feng Guo, Charlie CL Xue, Anthony Zhang, Yuhong Yan, Weifeng Zeng, Interventions for chronic idiopathic urticaria excluding antihistamines, The Cochrane Library,
  263. 263
    Claus Kroegel, Martin Foerster, Omalizumab (Xolair) – Anti-Immunoglobulin E Treatment in Allergic Diseases,